12 Most Promising Future Stocks According to Wall Street Analysts

Page 7 of 11

5. BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)

Analyst Upside: 70.61%

Number of Hedge Fund Holders: 59

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) is one of the most promising future stocks according to Wall Street analysts. In a report released on August 13, Gena Wang from Barclays maintained a Buy rating on BioMarin Pharmaceutical Inc. (NASDAQ:BMRN), with a price target of $86.00.

The rating update came after BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) reported its fiscal Q2 2025 results on August 4, with total revenues reaching $825 million, up 16% year-over-year and up 17% at constant currency year-over-year.

GAAP diluted earnings per share (EPS) for the quarter was $1.23, up 124% year-over-year, while non-GAAP diluted EPS reached $1.44, up 50% year-over-year.

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) develops and commercializes therapies for serious and life-threatening medical conditions and rare diseases. The company’s product pipeline includes Valoctocogene roxaparvovec, Vosoritide, and BMN 307.

Page 7 of 11